Tag Archives: Quest Focus Diagnostics

April, 2016

  • 29 April

    FDA Authorizes Quest’s Zika Test for Emergency Use

    MADISON, N.J., April 28, 2016 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The test …